Cancer Patients May Overly Self-Refer to Emergency Department
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 31, 2023 -- Adults with cancer may not be using available clinician advice before self-referring to the emergency department, according to a study published online Sept. 14 in the American Journal of Managed Care.
Arthur S. Hong, M.D., M.P.H., from the University of Texas Southwestern Medical Center in Dallas, and colleagues used tumor registry records (university patients diagnosed 2008 to 2018 and safety-net patients diagnosed 2012 to 2018) and linked electronic health records and a regional health information exchange to analyze how well cancer patients self-triage based on diagnosis code-based severity of emergency department visits. The analysis included 39,498 adults with 38,944 emergency department visits to 67 hospitals.
The researchers found that patients self-referred for 85.5 percent of visits and bypassed a median of 13 closer emergency departments. Visits made at emergency departments that were closer to home were not significantly more clinically severe. Furthermore, visits were significantly less severe if the patient self-referred (adjusted odds ratio, 0.89) or they were on weekends (adjusted odds ratio, 0.93). Findings were similar when reanalyzing data within each individual health system.
"Our findings suggest that upstream patient decisions leading to an emergency department visit may be influenced by nonclinical factors and that there are opportunities to maximize existing clinical resources to optimize acute care coordination," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Vaginal Cancer Incidence Increasing Globally
WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.